Richard Justice
Directeur Financier/CFO chez Mie Pay Ltd.
Profil
Richard Justice is currently the Chief Financial Officer at Mie Pay Ltd.
He previously worked as a Secretary at New Talisman Gold Mines Ltd., and as the Chief Financial Officer at Algorae Pharmaceuticals Ltd.
and Photonz Corp.
Ltd.
Mr. Justice obtained an undergraduate degree and an MBA from Auckland University.
Postes actifs de Richard Justice
| Sociétés | Poste | Début |
|---|---|---|
Mie Pay Ltd.
 Mie Pay Ltd. Packaged SoftwareTechnology Services Mie Pay Ltd. is a holding company, which engages in the provision of E-commerce and payments platform. The company was founded on November 1, 2018 and is headquartered in Sydney, Australia. | Directeur Financier/CFO | 04/11/2019 |
Anciens postes connus de Richard Justice
| Sociétés | Poste | Fin |
|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Directeur Financier/CFO | - |
| NEW TALISMAN GOLD MINES LIMITED | Secrétaire Général | - |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Directeur Financier/CFO | - |
Formation de Richard Justice
| Auckland University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEW TALISMAN GOLD MINES LIMITED | Non-Energy Minerals |
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
 | Technology Services |
| Entreprise privées | 1 |
|---|---|
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |
